a1909i
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of March 2024
Commission
File Number 001-15170
GSK plc
(Translation
of registrant's name into English)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK plc
(the 'Company')
Publication of Notice of Annual General Meeting 2024
The Company has today published on its website (www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/) the
Notice of Annual General Meeting ('AGM') 2024 (the '2024 AGM
Notice'), which will be distributed to shareholders
shortly.
The Company's AGM will be held on Wednesday 8 May 2024 at 2.30pm at
Royal Lancaster London, Lancaster Terrace, London W2 2TY and will
also be broadcast live for shareholders to join
electronically. Full details of how to join the
meeting either in person or electronically are contained in the
2024 AGM Notice and AGM Guide.
In compliance with Listing Rule 9.6.1R of the UK Financial Conduct
Authority's ('FCA') Listing Rules, the 2024 AGM Notice and Proxy
Form for the AGM will be submitted to the FCA and will, in due
course, be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
V A Whyte
Company Secretary
25 March 2024
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
|
|
GSK plc
|
|
|
(Registrant)
|
|
|
|
|
Date: March
25, 2024
|
|
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
|
|
Victoria Whyte
|
|
|
Authorised
Signatory for and on
|
|
|
behalf
of GSK plc
|
エドガーで原本を確認する